IR-MED Inc. has recently released an amendment to its management certification for the financial results ending December 31, 2024. This update, requested by OTC Markets Group, is a restatement of the original publication made on May 12, 2025. The company confirms that the information provided is accurate and complete to the best of its knowledge. The restated document highlights IR-MED Inc.'s compliance with SEC reporting obligations and other regulatory requirements. Additionally, the company maintains its commitment to timely disclose material information in line with U.S. federal securities laws. IR-MED Inc. assures stakeholders of its good standing and organized structure under the relevant jurisdictional laws.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。